Alteration of Tear Metabolomics Profiling in Infants With Retinopathy of Prematurity
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.6.61 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Zixin Fan and 8 co-authors. Institution: Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, Guangdong, China. Major MEDLINE topics: Retinopathy of Prematurity, Tears, Metabolomics. 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
The purpose of this study was to investigate the characteristics of metabolomic profile in the tears from infants with retinopathy of prematurity (ROP) and further define noninvasive biomarkers.
Methods
This prospective study included 94 eyes from 47 premature infants. Tear samples from 23 infants with ROP (15 treatment-requiring ones [ROP (t)] and 8 non-treatment-requiring ones [ROP (nt)]) and 24 infants without ROP were collected with Schirmer strips after topical anesthesia. Detailed fundus examination upon pupil dilation were conducted, with data on demographics and birth history recorded. Untargeted tear metabolomic analysis based on ultra-performance liquid chromatography-mass spectrometry was performed.
Results
Adjusted by sex, postmenstrual age, gestational age, and birth weight, among 145 metabolites quantified, 3,5-di-tert-butyl-4-hydroxybenzaldehyde, caffeine, and trehalose were identified to be upregulated in the tears from infants with ROP when compared to those from premature infants with non-ROP, whereas uric acid, dihomo-γ-linolenic acid, nootkatone, pyridoxal, ornithine, 6-keto-prostaglandin F1 alpha, adenosine, and tetrahydrocortisol were downregulated (all adjusted false discovery rate [FDR adj] < 0.05). Nine and one dysregulated metabolites were further found in the ROP (t) and ROP (nt) subgroups, respectively. Some of these metabolites exhibited expression levels correlated with postmenstrual age, gestational age, birth weight, and ROP severity in varying degrees. The dysregulated tear metabolites were fundamentally related to vitamin B6, purine, caffeine, arginine, and starch and sucrose metabolism pathways. The 6-keto-prostaglandin F1 alpha obtained the best performance in classifying premature infants with and without ROP (area under the curve [AUC] of 0.893 [range = 0.800-0.986], P < 0.001).
Conclusions
Dysregulated tear metabolites in ROP exhibited abundance correlated with severity of the disease and might be noninvasive biomarkers that potentially serve as complementary screening tools.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, Guangdong, China.
- New York University, New York, New York, United States.
- Sustech Core Research Facilities, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Cite
APA
Fan, Z., Yang, S., Lu, X., Zhang, S., Zeng, X., Lin, L., Yuan, D., Zeng, J., & Zhang, G. (2025). Alteration of Tear Metabolomics Profiling in Infants With Retinopathy of Prematurity. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.6.61
Vancouver
Fan Z, Yang S, Lu X, Zhang S, Zeng X, Lin L, et al. Alteration of Tear Metabolomics Profiling in Infants With Retinopathy of Prematurity. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.6.61
BibTeX
@article{Fan2025,
author = {Fan, Zixin and Yang, Shuo and Lu, Xiaofeng and Zhang, Sifan and Zeng, Xianlu and Lin, Lin and Yuan, Duo and Zeng, Jian and Zhang, Guoming},
title = {Alteration of Tear Metabolomics Profiling in Infants With Retinopathy of Prematurity},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.6.61}
}
EUVIMED